Graphique du cours de l'action PPBT
PPBT Gagner
Purple Biotech Ltd
$4.12
5.49%
$0.21
À la fermeture : May 08, 16:00:00 GMT-4
$3.95
-4.24%
$-0.17
Post-Marché: May 08, 20:00:00 GMT-4
Retour
Purple Biotech Ltd (PPBT) Gagner
Statistiques clés
Clôture préc.
$3.91
Prix d'ouverture
$4.08
Plage de la journée
$3.95 - $4.19
Plage de 52 semaines
$3.6 - $29
Volume
3.3K
Volume moyen
13.3K
Rendement en dividend
--
BPA (TTM)
-54.00
Capitalisation boursière
$3.6M
Qu’est-ce que Purple Biotech Ltd. ?
Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 10 full-time employees. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Fonctionnalités
© 2026 Edgen fonctionné par